SAN DIEGO, Sept. 26, 2017 /PRNewswire/ -- OncoSec
Medical Incorporated ("OncoSec") (NASDAQ:ONCS), a company
developing DNA-based intratumoral cancer immunotherapies, today
announced that Punit Dhillon, CEO
and President of OncoSec, will present at the Cantor Fitzgerald
Global Healthcare Conference on Wednesday,
September 27, 2017 at 4:35 PM
ET / 1:35 PM PT. The
conference will take place at the Intercontinental New York Barclay
Hotel.
To view the live webcast, please access the following link at
the time of the
presentation: http://wsw.com/webcast/cantor6/oncs. An archived
version of the webcast will be available for 90 days on OncoSec's
website: http://www.oncosec.com.
About OncoSec Medical Incorporated
OncoSec is a
biotechnology company developing DNA-based intratumoral
immunotherapies with an investigational technology, ImmunoPulse®,
for the treatment of cancer. ImmunoPulse® is designed to
enhance the local delivery and uptake of DNA-based immune-targeting
agents, such as IL-12. In Phase I and II clinical trials,
ImmunoPulse® IL-12 has demonstrated a favorable safety profile
and evidence of anti-tumor activity in the treatment of various
solid tumors and has shown the potential to reach beyond the site
of local treatment to initiate a systemic immune response.
ImmunoPulse® IL-12, OncoSec's lead program, is currently in
clinical development for metastatic melanoma and triple-negative
breast cancer. The program's current focus is on the significant
unmet medical need in patients with melanoma who are refractory or
have relapsed on anti-PD-1 therapies. In addition to
ImmunoPulse® IL-12, the Company is also identifying and
developing new immune-targeting agents for use with the
ImmunoPulse® platform. For more information, please
visit www.oncosec.com.
CONTACT:
Investor Relations
OncoSec Medical Incorporated
855-662-6732
investors@oncosec.com
Media Relations
OncoSec Medical Incorporated
855-662-6732
media@oncosec.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/oncosec-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-300526031.html
SOURCE OncoSec Medical Incorporated